Can lurbinectedin cause birth defects?
Lurbinectedin can be harmful to an unborn baby. Chemotherapy medicines in this class can cause fetal harm, including birth defects, because they can interfere with normal cell division and growth during pregnancy.
What do pregnancy warnings for lurbinectedin typically say?
Drug labels and safety guidance for anticancer agents commonly include a pregnancy warning advising against use during pregnancy and recommending effective contraception during treatment. The key risk is fetal harm, which includes major birth defects and other developmental problems.
What should people do if they are pregnant or trying to conceive?
If pregnancy is possible, clinicians generally advise using effective birth control during treatment and discussing reproductive planning before therapy. For anyone who becomes pregnant while taking lurbinectedin, prompt contact with the oncology team is essential to review risks and next steps.
What about men taking lurbinectedin—can they cause birth defects?
As with many chemotherapy drugs, sperm exposure can pose genetic risk. The usual approach is to use contraception during treatment and for a period after the last dose, and to discuss fertility and conception timing with the treating team.
How long do contraception precautions last after the last dose?
The exact window depends on the prescribing information and the drug’s pharmacokinetics, so it is tied to the label for lurbinectedin in the relevant country/brand. Checking the specific package insert for the recommended duration after stopping treatment is the safest way to confirm timing.
If you share whether you’re asking about pregnancy in the person taking lurbinectedin or about a partner, and which country’s label you’re using, I can narrow this to the exact warning language and timing.